Éric Meyer
Impact in
- Cancer Research top 10%
- NF-κB Signaling Pathways
- Molecular Biology top 10%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
Papers in
- Oncology 7
- Cancer-related Molecular Pathways 4
- CAR-T cell therapy research 2
-
- interferon and immune responses 3
- Immune Cell Function and Interaction 1
- Immunodeficiency and Autoimmune Disorders 1
- Co-authors
- Klaus‐Michael Debatin (9 shared papers)Simone Fulda (8 shared papers)Barbara Dockhorn‐Dworniczak (1 shared paper)Frans van Valen (1 shared paper)Santos A. Susín (1 shared paper)Guido Kroemer (1 shared paper)Claudia Friesen (1 shared paper)Gudrun Strauß (2 shared papers)
- Journals
- Oncogene (3 papers)Blood (3 papers)Cell Death and Differentiation (1 paper)Biotechnology and Bioengineering (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Éric Meyer
11 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 280
- Molecular Biology 1.2k
- Oncology 408
- Immunology 321
- Toxicology 29
Countries citing papers authored by Éric Meyer
This map shows the geographic impact of Éric Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Meyer more than expected).
Fields of papers citing papers by Éric Meyer
This network shows the impact of papers produced by Éric Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Meyer. The network helps show where Éric Meyer may publish in the future.
Co-authors
The 24 scholars most cited alongside Éric Meyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 348 | |
| 2 | 2002 | 342 | |
| 3 | 2001 | 197 | |
| 4 | Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. | 2000 | 175 |
| 5 | 1999 | 166 | |
| 6 | 2000 | 116 | |
| 7 | 2002 | 111 | |
| 8 | 1999 | 76 | |
| 9 | 2005 | 57 | |
| 10 | 2000 | 12 | |
| 11 | Defective CD95-induced apoptosis in children with autoimmune lymphoproliferative syndrome (ALPS)/Canale-Smith-Syndrome (CSS) in the absence of CD95 mutations. | 1999 | 2 |
About Éric Meyer
Éric Meyer is a scholar working on Oncology, Immunology, Molecular Biology, Microbiology and Epidemiology, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Cancer-related Molecular Pathways (4 papers), interferon and immune responses (3 papers), CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (1 paper), Autophagy in Disease and Therapy (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper) and Antimicrobial Peptides and Activities (1 paper). The work is most often cited by research in Cancer Research (280 citations), Molecular Biology (1.2k citations), Oncology (408 citations), Immunology (321 citations) and Toxicology (29 citations). Éric Meyer has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Klaus‐Michael Debatin, Simone Fulda, Barbara Dockhorn‐Dworniczak, Frans van Valen, Santos A. Susín, Guido Kroemer, Claudia Friesen, Gudrun Strauß, Thomas Kammertoens and Wolfgang Uckert. Their work appears in journals such as Oncogene, Blood, Cell Death and Differentiation, Biotechnology and Bioengineering and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.